ABCs of secondary prevention of CHD: easier said than done
- 1 March 2001
- journal article
- editorial
- Published by Elsevier in The Lancet
- Vol. 357 (9261) , 972-973
- https://doi.org/10.1016/s0140-6736(00)04252-5
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Lifestyle and risk factor management and use of drug therapies in coronary patients from 15 countries. Principal results from EUROASPIRE II Euro Heart Survey ProgrammeEuropean Heart Journal, 2001
- The Lipid Treatment Assessment Project (L-TAP)Archives of internal medicine (1960), 2000
- The therapeutic gap — compliance with medication and guidelinesAtherosclerosis, 1999
- ACC/AHA/ACP-ASIM guidelines for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Management of Patients With Chronic Stable Angina)Journal of the American College of Cardiology, 1999
- Prevention of coronary heart disease in clinical practice Recommendations of the Second Joint Task Force of European and other Societies on Coronary PreventionEuropean Heart Journal, 1998
- Can Computerized Risk Profiles Help Patients Improve Their Coronary Risk? The Results of The Coronary Health Assessment Study (CHAS)Preventive Medicine, 1998
- Trends of prescribing patterns for the secondary prevention of myocardial infarction over a 13-year period.European Journal of Clinical Pharmacology, 1998
- The Sixth Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureArchives of internal medicine (1960), 1997
- EUROASPIRE: A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal resultsEuropean Heart Journal, 1997
- When to Start Cholesterol-Lowering Therapy in Patients With Coronary Heart DiseaseCirculation, 1997